BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30108986)

  • 1. Evaluation of A-ring fused pyridine d-modified androstane derivatives for antiproliferative and aldo-keto reductase 1C3 inhibitory activity.
    Savić MP; Ajduković JJ; Plavša JJ; Bekić SS; Ćelić AS; Klisurić OR; Jakimov DS; Petri ET; Djurendić EA
    Medchemcomm; 2018 Jun; 9(6):969-981. PubMed ID: 30108986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17(E)-picolinylidene androstane derivatives as potential inhibitors of prostate cancer cell growth: antiproliferative activity and molecular docking studies.
    Ajduković JJ; Djurendić EA; Petri ET; Klisurić OR; Celić AS; Sakač MN; Jakimov DS; Gaši KM
    Bioorg Med Chem; 2013 Dec; 21(23):7257-66. PubMed ID: 24148837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preselection of A- and B- modified d-homo lactone and d-seco androstane derivatives as potent compounds with antiproliferative activity against breast and prostate cancer cells - QSAR approach and molecular docking analysis.
    Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Vukić VR; Savić MP; Djurendić EA
    Eur J Pharm Sci; 2016 Oct; 93():107-13. PubMed ID: 27503457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new steroid-based hydrazide and (thio)semicarbazone compounds with anticancer properties.
    Janković ÐD; Šestić TL; Bekić SS; Savić MP; Ćelić AS; Scholda J; Kopp F; Marinović MA; Petri ET; Ajduković JJ
    J Steroid Biochem Mol Biol; 2024 May; 242():106545. PubMed ID: 38762058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural analysis and antitumor activity of novel 17α-picolyl and 17(E)-picolinylidene A-modified androstane derivatives.
    Ajduković JJ; Penov Gaši KM; Jakimov DS; Klisurić OR; Jovanović-Šanta SS; Sakač MN; Aleksić LD; Djurendić EA
    Bioorg Med Chem; 2015 Apr; 23(7):1557-68. PubMed ID: 25737400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone receptor binding, selectivity and cytotoxicity of steroid D-homo lactone loaded chitosan nanoparticles for the treatment of breast and prostate cancer cells.
    Kuzminac IZ; Ćelić AS; Bekić SS; Kojić V; Savić MP; Ignjatović NL
    Colloids Surf B Biointerfaces; 2022 Aug; 216():112597. PubMed ID: 35636320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and cytotoxic activity of some 17-picolyl and 17-picolinylidene androstane derivatives.
    Djurendić EA; Ajduković JJ; Sakač MN; Csanádi JJ; Kojić VV; Bogdanović GM; Penov Gaši KM
    Eur J Med Chem; 2012 Aug; 54():784-92. PubMed ID: 22770744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel D-modified heterocyclic androstane derivatives as potential anticancer agents: Synthesis, characterization, in vitro and in silico studies.
    Šestić TL; Ajduković JJ; Bekić SS; Ćelić AS; Stojanović ST; Najman SJ; Marinović MA; Petri ET; Škorić DĐ; Savić MP
    J Steroid Biochem Mol Biol; 2023 Oct; 233():106362. PubMed ID: 37451557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androstane derivatives induce apoptotic death in MDA-MB-231 breast cancer cells.
    Jakimov DS; Kojić VV; Aleksić LD; Bogdanović GM; Ajduković JJ; Djurendić EA; Penov Gaši KM; Sakač MN; Jovanović-Šanta SS
    Bioorg Med Chem; 2015 Nov; 23(22):7189-98. PubMed ID: 26494582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray structure of human aldo-keto reductase 1C3 in complex with a bile acid fused tetrazole inhibitor: experimental validation, molecular docking and structural analysis.
    Marinović MA; Bekić SS; Kugler M; Brynda J; Škerlová J; Škorić DĐ; Řezáčová P; Petri ET; Ćelić AS
    RSC Med Chem; 2023 Feb; 14(2):341-355. PubMed ID: 36846371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of some epoxy and/or N-oxy 17-picolyl and 17-picolinylidene-androst-5-ene derivatives and evaluation of their biological activity.
    Djurendić E; Daljev J; Sakac M; Canadi J; Santa SJ; Andrić S; Klisurić O; Kojić V; Bogdanović G; Djurendić-Brenesel M; Novaković S; Gasi KP
    Steroids; 2008 Jan; 73(1):129-38. PubMed ID: 17963806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward steroidal anticancer drugs: Non-parametric and 3D-QSAR modeling of 17-picolyl and 17-picolinylidene androstanes with antiproliferative activity on breast adenocarcinoma cells.
    Kovačević SZ; Karadžić MŽ; Vukić DV; Vukić VR; Podunavac-Kuzmanović SO; Jevrić LR; Ajduković JJ
    J Mol Graph Model; 2019 Mar; 87():240-249. PubMed ID: 30594032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico ADMET analysis of the A-, B- and D-modified androstane derivatives with potential anticancer effects.
    Šestić TL; Ajduković JJ; Marinović MA; Petri ET; Savić MP
    Steroids; 2023 Jan; 189():109147. PubMed ID: 36410412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis,
    Stevanović MZ; Bekić SS; Petri ET; Ćelić AS; Jakimov DS; Sakač MN; Kuzminac IZ
    Future Med Chem; 2024 Apr; ():. PubMed ID: 38629440
    [No Abstract]   [Full Text] [Related]  

  • 15. New steroidal lactones as 5α-reductase inhibitors and antagonists for the androgen receptor.
    Garrido M; Bratoeff E; Bonilla D; Soriano J; Heuze Y; Cabeza M
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):367-73. PubMed ID: 21782943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of new D-seco and D-homo androstane derivatives.
    Djurendić EA; Zavis MP; Sakac MN; Canadi JJ; Kojić VV; Bogdanović GM; Penov Gasi KM
    Steroids; 2009 Nov; 74(12):983-8. PubMed ID: 19646459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor potential of novel 5α,6β-dibromo steroidal D-homo lactone.
    Kuzminac IZ; Bekić SS; Ćelić AS; Jakimov DS; Sakač MN
    Steroids; 2022 Dec; 188():109118. PubMed ID: 36183814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective aldo-keto reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid.
    Pippione AC; Carnovale IM; Bonanni D; Sini M; Goyal P; Marini E; Pors K; Adinolfi S; Zonari D; Festuccia C; Wahlgren WY; Friemann R; Bagnati R; Boschi D; Oliaro-Bosso S; Lolli ML
    Eur J Med Chem; 2018 Apr; 150():930-945. PubMed ID: 29602039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive QSRR modeling as a starting point in characterization and further development of anticancer drugs based on 17α-picolyl and 17(E)-picolinylidene androstane structures.
    Kovačević SZ; Podunavac-Kuzmanović SO; Jevrić LR; Jovanov PT; Djurendić EA; Ajduković JJ
    Eur J Pharm Sci; 2016 Oct; 93():1-10. PubMed ID: 27418311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-pot synthesis of new A-ring fused steroidal pyridines.
    Yan JZ; Li J; Rao GW
    Steroids; 2007 Oct; 72(11-12):736-9. PubMed ID: 17686502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.